[Translation] A randomized, parallel-group, double-blind, open-label, placebo-controlled, multicenter study to evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids
本研究的主要目的是证明在子宫肌瘤受试者中 vilaprisan 治疗月经过多(HMB)相对安慰剂的优效性。次要目的是额外评价 vilaprisan 在子宫肌瘤受试者中的有效性和安全性。
[Translation] The primary objective of this study was to demonstrate the superiority of vilaprisan over placebo in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids. Secondary objectives were to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.